ID   TYRO3_HUMAN             Reviewed;         890 AA.
AC   Q06418; O14953; Q86VR3;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   10-MAY-2017, entry version 177.
DE   RecName: Full=Tyrosine-protein kinase receptor TYRO3;
DE            EC=2.7.10.1;
DE   AltName: Full=Tyrosine-protein kinase BYK;
DE   AltName: Full=Tyrosine-protein kinase DTK;
DE   AltName: Full=Tyrosine-protein kinase RSE;
DE   AltName: Full=Tyrosine-protein kinase SKY;
DE   AltName: Full=Tyrosine-protein kinase TIF;
DE   Flags: Precursor;
GN   Name=TYRO3; Synonyms=BYK, DTK, RSE, SKY, TIF;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=7511603;
RA   Mark M.R., Scadden D.T., Wang Z., Gu Q., Goddard A., Godowski P.J.;
RT   "RSE, a novel receptor-type tyrosine kinase with homology to Axl/Ufo,
RT   is expressed at high levels in the brain.";
RL   J. Biol. Chem. 269:10720-10728(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=8108112;
RA   Ohashi K., Mizuno K., Kuma K., Miyata T., Nakamura T.;
RT   "Cloning of the cDNA for a novel receptor tyrosine kinase, Sky,
RT   predominantly expressed in brain.";
RL   Oncogene 9:699-705(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT VAL-815.
RC   TISSUE=Brain;
RX   PubMed=7857658; DOI=10.3109/08977199409001055;
RA   Crosier K.E., Hall L.R., Lewis P.M., Morris C.M., Wood C.R.,
RA   Morris J.C., Crosier P.S.;
RT   "Isolation and characterization of the human DTK receptor tyrosine
RT   kinase.";
RL   Growth Factors 11:137-144(1994).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   PubMed=9175267; DOI=10.1016/S0248-4900(97)86830-X;
RA   Kajii Y., Ninomiya D., Kato M., Mizuguchi M., Saji M., Katsumoto T.,
RA   Ohno K., Takashima S., Onodera K.;
RT   "A tyrosine kinase-like molecule is localized in the nuclear membrane
RT   of neurons: hippocampal behavior under stress.";
RL   Biol. Cell 88:45-54(1996).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS LEU-21; SER-542;
RP   MET-819 AND GLY-824.
RC   TISSUE=Skin, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 519-720.
RX   PubMed=8262388; DOI=10.1016/0378-1119(93)90109-G;
RA   Polvi A., Armstrong E., Lai C., Lemke G., Huebner K., Spritz R.A.,
RA   Giuda L.C., Nicholls R.D., Alitalo K.;
RT   "The human TYRO3 gene and pseudogene are located in chromosome 15q14-
RT   q25.";
RL   Gene 134:289-293(1993).
RN   [7]
RP   AUTOPHOSPHORYLATION.
RX   PubMed=7537495; DOI=10.1006/bbrc.1995.1549;
RA   Toshima J., Ohashi K., Iwashita S., Mizuno K.;
RT   "Autophosphorylation activity and association with Src family kinase
RT   of Sky receptor tyrosine kinase.";
RL   Biochem. Biophys. Res. Commun. 209:656-663(1995).
RN   [8]
RP   INTERACTION WITH GAS6.
RX   PubMed=7634325; DOI=10.1016/0092-8674(95)90424-7;
RA   Godowski P.J., Mark M.R., Chen J., Sadick M.D., Raab H.,
RA   Hammonds R.G.;
RT   "Reevaluation of the roles of protein S and Gas6 as ligands for the
RT   receptor tyrosine kinase Rse/Tyro 3.";
RL   Cell 82:355-358(1995).
RN   [9]
RP   REVIEW ON FUNCTION.
RX   PubMed=16737840; DOI=10.1016/j.cytogfr.2006.04.004;
RA   Hafizi S., Dahlback B.;
RT   "Signalling and functional diversity within the Axl subfamily of
RT   receptor tyrosine kinases.";
RL   Cytokine Growth Factor Rev. 17:295-304(2006).
RN   [10]
RP   FUNCTION (MICROBIAL INFECTION).
RX   PubMed=17005688; DOI=10.1128/JVI.01157-06;
RA   Shimojima M., Takada A., Ebihara H., Neumann G., Fujioka K.,
RA   Irimura T., Jones S., Feldmann H., Kawaoka Y.;
RT   "Tyro3 family-mediated cell entry of Ebola and Marburg viruses.";
RL   J. Virol. 80:10109-10116(2006).
RN   [11]
RP   REVIEW ON FUNCTION.
RX   PubMed=18421305; DOI=10.1038/nri2303;
RA   Lemke G., Rothlin C.V.;
RT   "Immunobiology of the TAM receptors.";
RL   Nat. Rev. Immunol. 8:327-336(2008).
RN   [12]
RP   FUNCTION IN PLATELET ACTIVATION.
RX   PubMed=20546121; DOI=10.1111/j.1538-7836.2010.03935.x;
RA   Cosemans J.M., Van Kruchten R., Olieslagers S., Schurgers L.J.,
RA   Verheyen F.K., Munnix I.C., Waltenberger J., Angelillo-Scherrer A.,
RA   Hoylaerts M.F., Carmeliet P., Heemskerk J.W.;
RT   "Potentiating role of Gas6 and Tyro3, Axl and Mer (TAM) receptors in
RT   human and murine platelet activation and thrombus stabilization.";
RL   J. Thromb. Haemost. 8:1797-1808(2010).
RN   [13]
RP   FUNCTION (MICROBIAL INFECTION).
RX   PubMed=22156524; DOI=10.1128/JVI.06451-11;
RA   Shimojima M., Stroher U., Ebihara H., Feldmann H., Kawaoka Y.;
RT   "Identification of cell surface molecules involved in dystroglycan-
RT   independent Lassa virus cell entry.";
RL   J. Virol. 86:2067-2078(2012).
RN   [14]
RP   FUNCTION (MICROBIAL INFECTION).
RX   PubMed=22673088; DOI=10.1292/jvms.12-0176;
RA   Shimojima M., Kawaoka Y.;
RT   "Cell surface molecules involved in infection mediated by lymphocytic
RT   choriomeningitis virus glycoprotein.";
RL   J. Vet. Med. Sci. 74:1363-1366(2012).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-466 AND SER-818, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [16]
RP   FUNCTION (MICROBIAL INFECTION), AND REVIEW.
RX   PubMed=25277499; DOI=10.1016/j.virol.2014.09.009;
RA   Moller-Tank S., Maury W.;
RT   "Phosphatidylserine receptors: enhancers of enveloped virus entry and
RT   infection.";
RL   Virology 468:565-580(2014).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (1.96 ANGSTROMS) OF 41-222, SUBUNIT, INTERACTION
RP   WITH GAS6, MUTAGENESIS OF ILE-99, AND DISULFIDE BONDS.
RX   PubMed=14623883; DOI=10.1074/jbc.M311750200;
RA   Heiring C., Dahlbaeck B., Muller Y.A.;
RT   "Ligand recognition and homophilic interactions in Tyro3: structural
RT   insights into the Axl/Tyro3 receptor tyrosine kinase family.";
RL   J. Biol. Chem. 279:6952-6958(2004).
RN   [18]
RP   VARIANT [LARGE SCALE ANALYSIS] THR-831.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Receptor tyrosine kinase that transduces signals from
CC       the extracellular matrix into the cytoplasm by binding to several
CC       ligands including TULP1 or GAS6. Regulates many physiological
CC       processes including cell survival, migration and differentiation.
CC       Ligand binding at the cell surface induces dimerization and
CC       autophosphorylation of TYRO3 on its intracellular domain that
CC       provides docking sites for downstream signaling molecules.
CC       Following activation by ligand, interacts with PIK3R1 and thereby
CC       enhances PI3-kinase activity. Activates the AKT survival pathway,
CC       including nuclear translocation of NF-kappa-B and up-regulation of
CC       transcription of NF-kappa-B-regulated genes. TYRO3 signaling plays
CC       a role in various processes such as neuron protection from
CC       excitotoxic injury, platelet aggregation and cytoskeleton
CC       reorganization. Plays also an important role in inhibition of
CC       Toll-like receptors (TLRs)-mediated innate immune response by
CC       activating STAT1, which selectively induces production of
CC       suppressors of cytokine signaling SOCS1 and SOCS3.
CC       {ECO:0000269|PubMed:20546121}.
CC   -!- FUNCTION: (Microbial infection) Acts as a receptor for lassa virus
CC       and lymphocytic choriomeningitis virus, possibly through GAS6
CC       binding to phosphatidyl-serine at the surface of virion envelope
CC       (PubMed:25277499, PubMed:22156524, PubMed:22673088). Acts as a
CC       receptor for ebolavirus, possibly through GAS6 binding to
CC       phosphatidyl-serine at the surface of virion envelope
CC       (PubMed:17005688). {ECO:0000269|PubMed:17005688,
CC       ECO:0000269|PubMed:22156524, ECO:0000269|PubMed:22673088,
CC       ECO:0000269|PubMed:25277499}.
CC   -!- CATALYTIC ACTIVITY: ATP + a [protein]-L-tyrosine = ADP + a
CC       [protein]-L-tyrosine phosphate. {ECO:0000255|PROSITE-
CC       ProRule:PRU10028}.
CC   -!- SUBUNIT: Monomer and homodimer. Interacts (via N-terminus) with
CC       extracellular ligands TULP1 and GAS6 (By similarity). Interacts
CC       with PIK3R1; this interaction increases PI3-kinase activity (By
CC       similarity). {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q9Y5K2:KLK4; NbExp=3; IntAct=EBI-3951628, EBI-10224152;
CC       Q6A162:KRT40; NbExp=3; IntAct=EBI-3951628, EBI-10171697;
CC       P60409:KRTAP10-7; NbExp=3; IntAct=EBI-3951628, EBI-10172290;
CC       P60410:KRTAP10-8; NbExp=3; IntAct=EBI-3951628, EBI-10171774;
CC       P60411:KRTAP10-9; NbExp=3; IntAct=EBI-3951628, EBI-10172052;
CC       Q9BYR5:KRTAP4-2; NbExp=3; IntAct=EBI-3951628, EBI-10172511;
CC       P26371:KRTAP5-9; NbExp=4; IntAct=EBI-3951628, EBI-3958099;
CC       Q99750:MDFI; NbExp=3; IntAct=EBI-3951628, EBI-724076;
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Single-pass type I membrane
CC       protein.
CC   -!- TISSUE SPECIFICITY: Abundant in the brain and lower levels in
CC       other tissues.
CC   -!- PTM: Autophosphorylated.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. AXL/UFO subfamily. {ECO:0000255|PROSITE-
CC       ProRule:PRU00159}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA21781.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/TYRO3ID42739ch15q15.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U05682; AAA19236.1; -; mRNA.
DR   EMBL; D17517; BAA04467.1; -; mRNA.
DR   EMBL; U18934; AAC50070.1; -; mRNA.
DR   EMBL; D50479; BAA21781.1; ALT_INIT; mRNA.
DR   EMBL; BC049368; AAH49368.1; -; mRNA.
DR   EMBL; BC051756; AAH51756.1; -; mRNA.
DR   EMBL; X72886; CAA51396.1; -; mRNA.
DR   CCDS; CCDS10080.1; -.
DR   PIR; A53743; A53743.
DR   PIR; I38912; I38912.
DR   RefSeq; NP_001317193.1; NM_001330264.1.
DR   RefSeq; NP_006284.2; NM_006293.3.
DR   UniGene; Hs.381282; -.
DR   PDB; 1RHF; X-ray; 1.96 A; A/B=41-222.
DR   PDBsum; 1RHF; -.
DR   ProteinModelPortal; Q06418; -.
DR   SMR; Q06418; -.
DR   BioGrid; 113152; 26.
DR   IntAct; Q06418; 17.
DR   STRING; 9606.ENSP00000263798; -.
DR   BindingDB; Q06418; -.
DR   ChEMBL; CHEMBL5314; -.
DR   GuidetoPHARMACOLOGY; 1836; -.
DR   iPTMnet; Q06418; -.
DR   PhosphoSitePlus; Q06418; -.
DR   BioMuta; TYRO3; -.
DR   DMDM; 1717829; -.
DR   EPD; Q06418; -.
DR   MaxQB; Q06418; -.
DR   PaxDb; Q06418; -.
DR   PeptideAtlas; Q06418; -.
DR   PRIDE; Q06418; -.
DR   Ensembl; ENST00000263798; ENSP00000263798; ENSG00000092445.
DR   GeneID; 7301; -.
DR   KEGG; hsa:7301; -.
DR   UCSC; uc001zof.3; human.
DR   CTD; 7301; -.
DR   DisGeNET; 7301; -.
DR   GeneCards; TYRO3; -.
DR   HGNC; HGNC:12446; TYRO3.
DR   HPA; HPA071245; -.
DR   MIM; 600341; gene.
DR   neXtProt; NX_Q06418; -.
DR   OpenTargets; ENSG00000092445; -.
DR   PharmGKB; PA37097; -.
DR   eggNOG; ENOG410IG6I; Eukaryota.
DR   eggNOG; COG0515; LUCA.
DR   GeneTree; ENSGT00810000125384; -.
DR   HOVERGEN; HBG006346; -.
DR   InParanoid; Q06418; -.
DR   KO; K05116; -.
DR   OMA; GMEDPEM; -.
DR   OrthoDB; EOG091G016X; -.
DR   PhylomeDB; Q06418; -.
DR   TreeFam; TF317402; -.
DR   BRENDA; 2.7.10.1; 2681.
DR   SignaLink; Q06418; -.
DR   SIGNOR; Q06418; -.
DR   ChiTaRS; TYRO3; human.
DR   EvolutionaryTrace; Q06418; -.
DR   GeneWiki; TYRO3; -.
DR   GenomeRNAi; 7301; -.
DR   PRO; PR:Q06418; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   Bgee; ENSG00000092445; -.
DR   CleanEx; HS_TYRO3; -.
DR   ExpressionAtlas; Q06418; baseline and differential.
DR   Genevisible; Q06418; HS.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; ISS:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; NAS:UniProtKB.
DR   GO; GO:0005635; C:nuclear envelope; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0043548; F:phosphatidylinositol 3-kinase binding; IPI:UniProtKB.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:Ensembl.
DR   GO; GO:0004713; F:protein tyrosine kinase activity; IDA:UniProtKB.
DR   GO; GO:0004716; F:signal transducer, downstream of receptor, with protein tyrosine kinase activity; NAS:UniProtKB.
DR   GO; GO:0004714; F:transmembrane receptor protein tyrosine kinase activity; NAS:UniProtKB.
DR   GO; GO:0001618; F:virus receptor activity; IEA:UniProtKB-KW.
DR   GO; GO:0043277; P:apoptotic cell clearance; ISS:UniProtKB.
DR   GO; GO:0007155; P:cell adhesion; NAS:UniProtKB.
DR   GO; GO:0021885; P:forebrain cell migration; ISS:UniProtKB.
DR   GO; GO:0001779; P:natural killer cell differentiation; IEA:Ensembl.
DR   GO; GO:0050728; P:negative regulation of inflammatory response; ISS:UniProtKB.
DR   GO; GO:0045824; P:negative regulation of innate immune response; ISS:UniProtKB.
DR   GO; GO:0051250; P:negative regulation of lymphocyte activation; IEA:Ensembl.
DR   GO; GO:0043524; P:negative regulation of neuron apoptotic process; ISS:UniProtKB.
DR   GO; GO:0034122; P:negative regulation of toll-like receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0070050; P:neuron cellular homeostasis; ISS:UniProtKB.
DR   GO; GO:0042698; P:ovulation cycle; ISS:UniProtKB.
DR   GO; GO:0014065; P:phosphatidylinositol 3-kinase signaling; NAS:UniProtKB.
DR   GO; GO:0030168; P:platelet activation; ISS:UniProtKB.
DR   GO; GO:0070527; P:platelet aggregation; ISS:UniProtKB.
DR   GO; GO:0046777; P:protein autophosphorylation; IDA:UniProtKB.
DR   GO; GO:0043491; P:protein kinase B signaling; ISS:UniProtKB.
DR   GO; GO:0032940; P:secretion by cell; ISS:UniProtKB.
DR   GO; GO:0007165; P:signal transduction; NAS:UniProtKB.
DR   GO; GO:0007283; P:spermatogenesis; ISS:UniProtKB.
DR   GO; GO:0034446; P:substrate adhesion-dependent cell spreading; ISS:UniProtKB.
DR   GO; GO:0060068; P:vagina development; IEA:Ensembl.
DR   CDD; cd00063; FN3; 2.
DR   Gene3D; 2.60.40.10; -; 4.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR008266; Tyr_kinase_AS.
DR   InterPro; IPR020635; Tyr_kinase_cat_dom.
DR   Pfam; PF00041; fn3; 2.
DR   Pfam; PF07679; I-set; 1.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00060; FN3; 2.
DR   SMART; SM00409; IG; 2.
DR   SMART; SM00408; IGc2; 2.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF48726; SSF48726; 2.
DR   SUPFAM; SSF49265; SSF49265; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS50853; FN3; 2.
DR   PROSITE; PS50835; IG_LIKE; 2.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Cell adhesion; Cell membrane;
KW   Complete proteome; Disulfide bond; Glycoprotein;
KW   Host cell receptor for virus entry; Host-virus interaction;
KW   Immunoglobulin domain; Kinase; Membrane; Nucleotide-binding;
KW   Phosphoprotein; Polymorphism; Receptor; Reference proteome; Repeat;
KW   Signal; Transferase; Transmembrane; Transmembrane helix;
KW   Tyrosine-protein kinase.
FT   SIGNAL        1     40       {ECO:0000255}.
FT   CHAIN        41    890       Tyrosine-protein kinase receptor TYRO3.
FT                                /FTId=PRO_0000024478.
FT   TOPO_DOM     41    429       Extracellular. {ECO:0000255}.
FT   TRANSMEM    430    450       Helical. {ECO:0000255}.
FT   TOPO_DOM    451    890       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       41    128       Ig-like C2-type 1.
FT   DOMAIN      139    220       Ig-like C2-type 2.
FT   DOMAIN      227    320       Fibronectin type-III 1.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      325    416       Fibronectin type-III 2.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      518    790       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND     524    532       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   ACT_SITE    655    655       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10028}.
FT   BINDING     550    550       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES     466    466       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     681    681       Phosphotyrosine; by autocatalysis.
FT                                {ECO:0000250}.
FT   MOD_RES     685    685       Phosphotyrosine; by autocatalysis.
FT                                {ECO:0000250}.
FT   MOD_RES     686    686       Phosphotyrosine; by autocatalysis.
FT                                {ECO:0000250}.
FT   MOD_RES     804    804       Phosphotyrosine; by autocatalysis.
FT                                {ECO:0000250}.
FT   MOD_RES     818    818       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     869    869       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P55146}.
FT   CARBOHYD     63     63       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    191    191       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    230    230       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    240    240       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    293    293       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    366    366       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    380    380       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     64    117       {ECO:0000255|PROSITE-ProRule:PRU00114,
FT                                ECO:0000269|PubMed:14623883}.
FT   DISULFID    160    203       {ECO:0000255|PROSITE-ProRule:PRU00114,
FT                                ECO:0000269|PubMed:14623883}.
FT   VARIANT      21     21       P -> L (in dbSNP:rs17854578).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_045886.
FT   VARIANT     346    346       I -> N (in dbSNP:rs12148316).
FT                                /FTId=VAR_045887.
FT   VARIANT     542    542       G -> S (in dbSNP:rs17857363).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_045888.
FT   VARIANT     815    815       A -> V (in dbSNP:rs1042057).
FT                                {ECO:0000269|PubMed:7857658}.
FT                                /FTId=VAR_045889.
FT   VARIANT     819    819       L -> M (in dbSNP:rs17854579).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_045890.
FT   VARIANT     824    824       R -> G (in dbSNP:rs17857364).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_045891.
FT   VARIANT     831    831       A -> T. {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041876.
FT   MUTAGEN      99     99       I->R: Abolishes dimerization.
FT                                {ECO:0000269|PubMed:14623883}.
FT   CONFLICT     29     36       Missing (in Ref. 3; AAC50070).
FT                                {ECO:0000305}.
FT   CONFLICT    285    285       L -> F (in Ref. 4; BAA21781).
FT                                {ECO:0000305}.
FT   CONFLICT    293    293       N -> I (in Ref. 4; BAA21781).
FT                                {ECO:0000305}.
FT   CONFLICT    341    341       E -> V (in Ref. 4; BAA21781).
FT                                {ECO:0000305}.
FT   CONFLICT    812    812       E -> D (in Ref. 4; BAA21781).
FT                                {ECO:0000305}.
FT   STRAND       50     55       {ECO:0000244|PDB:1RHF}.
FT   STRAND       60     68       {ECO:0000244|PDB:1RHF}.
FT   STRAND       74     78       {ECO:0000244|PDB:1RHF}.
FT   STRAND       85     94       {ECO:0000244|PDB:1RHF}.
FT   STRAND       97    106       {ECO:0000244|PDB:1RHF}.
FT   HELIX       109    111       {ECO:0000244|PDB:1RHF}.
FT   STRAND      113    121       {ECO:0000244|PDB:1RHF}.
FT   STRAND      131    136       {ECO:0000244|PDB:1RHF}.
FT   STRAND      140    143       {ECO:0000244|PDB:1RHF}.
FT   STRAND      148    150       {ECO:0000244|PDB:1RHF}.
FT   STRAND      156    163       {ECO:0000244|PDB:1RHF}.
FT   STRAND      165    167       {ECO:0000244|PDB:1RHF}.
FT   STRAND      170    175       {ECO:0000244|PDB:1RHF}.
FT   STRAND      183    192       {ECO:0000244|PDB:1RHF}.
FT   STRAND      199    207       {ECO:0000244|PDB:1RHF}.
FT   STRAND      210    213       {ECO:0000244|PDB:1RHF}.
FT   STRAND      217    221       {ECO:0000244|PDB:1RHF}.
SQ   SEQUENCE   890 AA;  96905 MW;  F9EC675077C4E8F1 CRC64;
     MALRRSMGRP GLPPLPLPPP PRLGLLLAAL ASLLLPESAA AGLKLMGAPV KLTVSQGQPV
     KLNCSVEGME EPDIQWVKDG AVVQNLDQLY IPVSEQHWIG FLSLKSVERS DAGRYWCQVE
     DGGETEISQP VWLTVEGVPF FTVEPKDLAV PPNAPFQLSC EAVGPPEPVT IVWWRGTTKI
     GGPAPSPSVL NVTGVTQSTM FSCEAHNLKG LASSRTATVH LQALPAAPFN ITVTKLSSSN
     ASVAWMPGAD GRALLQSCTV QVTQAPGGWE VLAVVVPVPP FTCLLRDLVP ATNYSLRVRC
     ANALGPSPYA DWVPFQTKGL APASAPQNLH AIRTDSGLIL EWEEVIPEAP LEGPLGPYKL
     SWVQDNGTQD ELTVEGTRAN LTGWDPQKDL IVRVCVSNAV GCGPWSQPLV VSSHDRAGQQ
     GPPHSRTSWV PVVLGVLTAL VTAAALALIL LRKRRKETRF GQAFDSVMAR GEPAVHFRAA
     RSFNRERPER IEATLDSLGI SDELKEKLED VLIPEQQFTL GRMLGKGEFG SVREAQLKQE
     DGSFVKVAVK MLKADIIASS DIEEFLREAA CMKEFDHPHV AKLVGVSLRS RAKGRLPIPM
     VILPFMKHGD LHAFLLASRI GENPFNLPLQ TLIRFMVDIA CGMEYLSSRN FIHRDLAARN
     CMLAEDMTVC VADFGLSRKI YSGDYYRQGC ASKLPVKWLA LESLADNLYT VQSDVWAFGV
     TMWEIMTRGQ TPYAGIENAE IYNYLIGGNR LKQPPECMED VYDLMYQCWS ADPKQRPSFT
     CLRMELENIL GQLSVLSASQ DPLYINIERA EEPTAGGSLE LPGRDQPYSG AGDGSGMGAV
     GGTPSDCRYI LTPGGLAEQP GQAEHQPESP LNETQRLLLL QQGLLPHSSC
//
